Related Experiment Video
Updated: Nov 25, 2025

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Editors' presentation: Focus on short communications in cardiovascular prevention
Geza Halasz1, Massimo F Piepoli1,2
1Cardiac Unit, G da Saliceto Hospital, Parma, Italy.
No abstract available in PubMed .
More Related Videos
08:21Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
04:44Author Spotlight: Enhancing Vascular Function and Physical Capacity in Cardiovascular Disease Through Novel Interventions and NIRS Technology
Published on: March 22, 2024
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Atherosclerosis III: Management
Cardiomyopathy V: Interprofessional Care
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...